"Street-wide" changes in investment research availability?

Analysts:

The news being fed to us here is that due to some collapsed partnerships over the past couple of months, there has been a street-wide change to the way investment research is shared/bought. I'm not sure how much truth is in this. Anyone else experiencing drastically reduced research availability?

FYI, we went from having all research to having a very limited assortment of research, with a brand new process in place by which we have to request/justify/struggle with our overseas data shop at four in the morning so that eventually, someday, they might deign to send us the report we wanted.

So is this the whole street, or is it just us? I have a feeling that it hurts us worse than most other BBs.

 

Come on, guys. This is one of the most serious and on-topic threads created today, and you guys would rather discuss ties? I know there are some real working analysts out there. Let's share some information here.

 

Yeah, there's been a change at my bank. Someone said that the cost has gone up to $500 per access, but that's just a rumor. Regardless, we need approval to access reports on our system. It really sucks.

 

Ah. So some of us are feeling it and some of us are not. Will be interesting to see if it trickles down/up over the coming months.

 

So true...we use Thompson Analytics at my firm and it's embarassing when the client has access to research reports that we do not. Plus, the lack of research has made my life hell at times, forcing me to spend even more time data mining in my cube for one-line of information that may or may not exist..

Not to mention, that website is perhaps the worst/least convienant to use...so many bugs and the search engines continually miss things. I just love an associate and I do a full search in Thompson and look through a ton of research reports, only to have the VP find what he was looking for in five minutes. I love looking like an idiot.

Anyone else have a similar experience?

 

I used to get a full set of credible BB broker reports off Thomson, but it seems to be shifting towards a whole set of dodgy outfits.

These reports sell through Thomson at something like USD 7 per page to banks and a lot less to academic institutions, when I hear UBS (not on Thomson) sells them for USD 500 up to a few thousand. Granted distribution is more limited without Thomson, that's still quite a big price difference.

Thomson IBES has also been removed from BBG... the guys must be going through a rough patch.

 

Great. Well, let's keep a periodic conversation up about this, folks. I would like to stay informed about what's going on across the street, as research changes hit us analysts the hardest of all.

Particularly when I'm on the phone with Mumbai at four in the fricking morning trying to prove that yes, I really do need the research, and yes, I do know how much it costs.

 
Best Response

Yea the MarketsPro consortium: MS, ML, Citi, JPM, UBS, Lehman

Is being somewhat disbanded as research is deemed to be too cheap.

Thomson research has some Bulge, but it's mostly the one-off shops like, CIBC, Baird, Jefferies. At MS we only use Bulge research unless there is no coverage.

Gonna be a bitch.

-- Interview Guides GMAT Tutors WSO Resume Review --- Current: Senior Analyst - Hedge Fund Past: Associate - Tech Buyout Analyst - Morgan St
 

Atque velit quasi quia pariatur molestiae enim rem. Non autem qui id voluptatibus rerum autem. Blanditiis recusandae optio at. Et totam consequuntur vitae necessitatibus dolor qui occaecati. Voluptatem officia nisi deleniti ipsum quibusdam delectus saepe.

Repellendus aliquid ipsa eligendi voluptatibus quis assumenda est. Praesentium eius corrupti repudiandae qui velit rem quos ipsa. Voluptas tempora sit eius placeat rerum voluptatem perspiciatis. Odio est minima soluta asperiores molestiae eos. Pariatur numquam ut illo voluptates dignissimos. Ex accusantium similique dolor aliquid id dolor dolorem doloribus.

Sed est accusantium cupiditate nihil corporis fugit. Consequatur accusantium accusantium eius non sapiente repellendus dolorem. Accusantium laudantium est dolores et illum. Excepturi minima rem non doloribus ex. Nulla saepe sed aliquam accusantium consectetur.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 16 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Perella Weinberg Partners New 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 06 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (148) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”